Pasireotide (acetate)Pasireotide (acetate) - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-16381A-01.804-HY-16381A-01804-HY-16381A-01Business & Industrial > Science & LaboratoryPasireotide (acetate)
Gentaur
EUR12027-02-19

Pasireotide (acetate)

CAT:
804-HY-16381A-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pasireotide (acetate) - image 1

Pasireotide (acetate)

  • Description:

    Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/[1][2][3].
  • Product Name Alternative:

    SOM230 (acetate)
  • UNSPSC:

    12352209
  • Target:

    Somatostatin Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein; Neuronal Signaling
  • Applications:

    Metabolism-sugar/lipid metabolism
  • Field of Research:

    Cancer; Endocrinology
  • Assay Protocol:

    https://www.medchemexpress.com/pasireotide-acetate.html
  • Purity:

    99.25
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic) |H2O : 1 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    NCCCC[C@@H](C(N[C@H]1CC2=CC=C(C=C2)OCC3=CC=CC=C3)=O)NC([C@H](NC([C@H](C4=CC=CC=C4)NC([C@H]5N(C([C@H](CC6=CC=CC=C6)NC1=O)=O)C[C@H](OC(NCCN)=O)C5)=O)=O)CC7=CNC8=C7C=CC=C8)=O.CC(O)=O
  • Molecular Formula:

    C60H70N10O11
  • Molecular Weight:

    1107.26
  • References & Citations:

    [1]Lewis I, et, al. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J Med Chem. 2003 Jun 5;46 (12) :2334-44.|[2]Quinn TJ, et, al. Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. Surgery. 2012 Dec;152 (6) :1068-77.|[3]Imhof AK, et, al. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis Rheum. 2011 Aug;63 (8) :2352-62.|[4]Imhof AK, et, al. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Arthritis Rheum. 2011 Aug;63 (8) :2352-62.|[5]Schmid HA, et, al. Pasireotide (SOM230) : development, mechanism of action and potential applications. Mol Cell Endocrinol. 2008 May 14;286 (1-2) :69-74.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
  • Scientific Category:

    Peptides
  • Clinical Information:

    Launched
  • CAS Number:

    [396091-76-2]